Detection of Heart Conditions Using Artificial Intelligence

NCT04933890 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2022-12-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate how Eko AI performs in the real world, front-line setting where the availability of sophisticated, expensive diagnostic tools is limited, and where there is a premium on detecting VHD early in its course.

Conditions

Interventions

DEVICE

Use of Eko DUO electronic stethoscope

Auscultation of heart sounds using electronic stethoscope

Sponsors & Collaborators

  • Eko Devices, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04933890 on ClinicalTrials.gov